Page last updated: 2024-11-05

xylazine and Acquired Immunodeficiency Syndrome

xylazine has been researched along with Acquired Immunodeficiency Syndrome in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez, N1
Vargas Vidot, J1
Panelli, J1
Colón, H1
Ritchie, B1
Yamamura, Y1

Other Studies

1 other study available for xylazine and Acquired Immunodeficiency Syndrome

ArticleYear
GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles.
    Drug and alcohol dependence, 2008, Aug-01, Volume: 96, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adrenergic alpha-Agonists; Adult; Female; Gas Chroma

2008